1.Comparison of Intravaginal Misoprostol and Prostaglandin E2 Vaginal Tablet in Termination of Mid - Trimester Pregnancy.
Korean Journal of Obstetrics and Gynecology 1999;42(2):388-391
OBJECTIVE: To compsre the efficiency, success rate, and abortion time of applications of intravaginal misoprostol versus prostaglandin E2 vaginal tablet for mid-trimester pregnancy termination Subjects and methods: Eighty four patients between 17-29 weeks of gestation with medical, obstetric, or genetic reasons far termination were randomized to receive either 50 ug tablets of misoprostol placed in the posterior vaginal fornix or prostaglandin E2 3mg in tables placed into the endocervix. RESULTS: Among eighty four patients recruited, fourty five patients received misoprostol and thirty nine patients received prostaglandin E2 vaginal tablets. The average interval hom start of induction to vaginal delivery was 13.35 +/- 3.34 hours in misoprostol poup and 19.14 +/- 10.64 hours in the prostaglandin E2 group. The success rate of complete termination within 12 and 24 hours in misopr-ostol group were 57.7%, 93.3%, respectively, while in prostaglandin E2 group were 20.5%, 82.1% repectively. Oxytocin augumentation was 6.7% in misoprostol group and 17.9% in the prostaglardin E2 group. No serious complication occumd. CONCLUSION: Intracervicovaginal misoprostol appears to be acceptably safe and effective agents for second trimester pregnancy termination. The abortion time is less in misoprostol group than those in the prostaglandin E2 group. Misoprostol has the advantage of being expensive, easily stored and readily available. We used 50 ug tablets of misoprostol every four hours. But, we suspect that the regimen of 100ug misopostol inserted intracervico-vaginally every eight hours will beis the proper and optimal method for pregnancy termination.
Dinoprostone*
;
Female
;
Humans
;
Misoprostol*
;
Oxytocin
;
Pregnancy Trimester, Second
;
Pregnancy*
;
Tablets
;
Vaginal Creams, Foams, and Jellies*
2.Alteratione of plasma antithrombin III in normal pregnancy and severe preeclampsia.
Taek Hoon KIM ; Jong In KIM ; Young Wook SUH
Korean Journal of Perinatology 1993;4(4):524-529
No abstract available.
Antithrombin III*
;
Plasma*
;
Pre-Eclampsia*
;
Pregnancy*
3.Amniotic fluid alpha-fetoprotein levels during midtrimester pregnancy (I).
Taek Hoon KIM ; Jong In KIM ; Hyo Jin CHUN
Korean Journal of Perinatology 1993;4(4):498-503
No abstract available.
alpha-Fetoproteins*
;
Amniotic Fluid*
;
Female
;
Humans
;
Pregnancy
;
Pregnancy Trimester, Second*
;
Pregnancy*
4.A case of intraperitoneal hemorrhage of round ligament pregnancy.
Heung Yeol KIM ; Taek Hoon KIM ; Sung Do YOON
Korean Journal of Obstetrics and Gynecology 1992;35(7):1092-1095
No abstract available.
Hemorrhage*
;
Pregnancy*
;
Round Ligament of Uterus*
5.Locus Ceruleus Terminals in the Fundus StriatiNucleus accumbens septi of the Cat : Electron Microscopic Study.
Taek Soo KIM ; Myung Hoon CHUN ; Jin Woong JUNG
Korean Journal of Anatomy 1997;30(4):421-430
Although the distribution of locus ceruleus terminals has been demonstrated in the fundus striati[nucleus accumbens septi] by light microscopy[Jones & Moore, 1977 ; Mason & Fibiger, 1979 ; Streit or et al., 1979 ; Groenewegen et al., 1980], the synaptic organization of its terminals was not clarified. The purpose of the present investigation was to demonstrate the direct monosynaptic connection of the locus ceruleus terminals to the neuronal elements of the fundus stirati, and to clarify the synaptic structures of its terminals by electron microscopy two days after unilateral electric coagulation of the locus ceruleus. In the ipsilateral fundus striati, many axon terminals undergone dark degeneration were observed. These degenerating terminals containing small clear vesicles have asymmetric synaptic contacts with dendritic spines. Already two days after locus ceruleus lesion, distinct features of terminal degenerations appeared in the fundus striati ; enlarged axon terminals with altered synaptic vesicles, decrease of synaptic vesicles detached from the synaptic site, multiplication of dense bodies and infiltration of floccular material. At the same time, a regressive change occurred in which astrocytic processes encircled totally degenerated synapses spiraled around the synaptic remnants. These observations indicate that monosynaptic noradrenertic afferent connections to the fungus striati are confirmed, and the locus ceruleus terminals characterized by small round vesicles might be formed asymmetrical axo-spinous synapses with spiny neurons in the fundus striati.
Animals
;
Cats*
;
Dendritic Spines
;
Fungi
;
Locus Coeruleus*
;
Microscopy, Electron
;
Neurons
;
Presynaptic Terminals
;
Synapses
;
Synaptic Vesicles
6.Ossification of the Coracoacromial Ligament in Subacromial Impingement Syndrome: A Case Report.
Kyupill MOON ; Youn Soo HWANG ; Kyung Taek KIM ; Jin Wan KIM ; Jeong Hoon CHAE
Clinics in Shoulder and Elbow 2017;20(3):167-171
Here, a case of a 59-year-old man with rotator cuff tear and impingement syndrome caused by an ossified coracoacromial ligament is presented. Ossification of the coracoacromial ligaments can occur because of degenerative changes due to trauma or repeated stress, which can lead to impingement syndrome. Therefore, when coracoacromial ligament ossification is present, rotator cuff damage due to impingement syndrome should be considered. Here, we conducted arthroscopic subacromial decompression, removal of the ossified coracoacromial ligament, and supraspinatus and subscapularis tendon repairs. We achieved satisfactory surgical outcomes without relapse; therefore, we report this case with a literature review.
Decompression
;
Humans
;
Ligaments*
;
Middle Aged
;
Recurrence
;
Rotator Cuff
;
Shoulder
;
Shoulder Impingement Syndrome*
;
Tears
;
Tendons
7.A case of consencutive infantile polycystic kidney in one nulliparous woman prenatal ultrasonographic diagnosis.
Tae Il CHUNG ; Se Chul PARK ; Mi Jung LEE ; Jong In KIM ; Taek Hoon KIM
Korean Journal of Perinatology 1993;4(1):87-93
No abstract available.
Diagnosis*
;
Female
;
Humans
;
Polycystic Kidney Diseases*
8.Cystic lesion with visible feeding vessel in chest PA.
Chul Hyun KIM ; Soo Taek UH ; Yeon Tae CHUNG ; Yong Hoon KIM ; Choon Sik PARK
Tuberculosis and Respiratory Diseases 1991;38(1):83-87
No abstract available.
Thorax*
9.Bone Marrow Pressure Study in Ostoenecrosis of the Femoral Head
Myung Chul YOO ; Ki Taek KIM ; Kyung Hoon KIM ; Seung Myeon PARK
The Journal of the Korean Orthopaedic Association 1986;21(5):799-811
Authors measured the bone marrow pressure(B.M.P.) of 59 femoral heads in cases of either suspicious or diagnosed osteonecrosis and obtained the significant relationship between increased B.M.P. and the osteonecrosis. Increased bone marrow pressure provided both predictive and early diagnostic importance in even the preclinical stage of evolution of the disease, which subsequently had core biopsy proved osteonecrosis of femoral head. The results obstained were as follows; 1. Roentgenographically apperent osteonecrosis showed abnormal B.M.P. pattern, which were proved by the core biopsy. 2. In 21 cases of preclinical osteonecrosis, which did not show roentgenographic changes of osteonecrosis, measured B.M.P. parterns indicated as early stage of osteonecrosis in core biopsy at all. 3. The incidence of abnormal pressure pattern I was 51% and that of pattern II was 30%. 4. Enneking radiological staging did not correlate with the results of B.M.P. 5. The measurement of B.M.P. is relatively easy and simple method without any remarkable risk. The results of this study had great meaning in emphasizing the contribution of the bone marrow pressure measurement dianosing the preclinical stage of osteonecrosis, which had no roentgenographical changes and diagnostic symptoms.
Biopsy
;
Bone Marrow
;
Head
;
Incidence
;
Methods
;
Osteonecrosis
10.Cutaneous Leishmaniasis Treated with Metronidazole and Cryotherapy.
Young Hoon YOON ; Miri KIM ; Shin Taek OH ; Baik Kee CHO ; Hyun Jeong PARK
Korean Journal of Dermatology 2015;53(7):576-578
No abstract available.
Cryotherapy*
;
Leishmaniasis, Cutaneous*
;
Metronidazole*